I think kickstarter has hit the nail on the head... Kazia isn't a US company so it is way behind being able to compete against a local competitor. It's main hope is to get bought out by the competition if it's drug is much better.
Disclaimer : I know little about biotechs.
Add to My Watchlist
What is My Watchlist?